Literature DB >> 11024130

Incoming human cytomegalovirus pp65 (UL83) contained in apoptotic infected fibroblasts is cross-presented to CD8(+) T cells by dendritic cells.

G Arrode1, C Boccaccio, J Lulé, S Allart, N Moinard, J P Abastado, A Alam, C Davrinche.   

Abstract

Human cytomegalovirus (HCMV) infection is well controlled mainly by cytotoxic CD8(+) T lymphocytes (CTL) directed against the matrix protein pp65 despite the numerous immune escape mechanisms developed by the virus. Dendritic cells (DCs) are key antigen-presenting cells for the generation of an immune response which have the capacity to acquire antigens via endocytosis of apoptotic cells and thus present peptides to major histocompatibility complex class I-restricted T cells. We examined whether this mechanism could contribute to the activation of anti-pp65 CTL. In this study, we show that infection by HCMV AD169 induced sensitization of MRC5 fibroblasts to tumor necrosis factor alpha-mediated apoptosis very early after virus inoculation and that pp65 contained in apoptotic cells came from the delivery of the matrix protein into the cell. We observed that immature DCs derived from peripheral monocytes were not permissive to HCMV AD169 infection but were able to internalize pp65-positive apoptotic infected MRC5 cells. We then demonstrated that following exposure to these apoptotic bodies, DCs could activate HLA-A2- or HLA-B35-restricted anti-pp65 CTL, suggesting that they acquired and processed properly fibroblast-derived pp65. Together, our data suggest that cross-presentation of incoming pp65 contained in apoptotic cells may provide a quick and efficient way to prime anti-HCMV CD8(+) T cells.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11024130      PMCID: PMC102040          DOI: 10.1128/jvi.74.21.10018-10024.2000

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  A cytomegalovirus-encoded mitochondria-localized inhibitor of apoptosis structurally unrelated to Bcl-2.

Authors:  V S Goldmacher; L M Bartle; A Skaletskaya; C A Dionne; N L Kedersha; C A Vater; J W Han; R J Lutz; S Watanabe; E D Cahir McFarland; E D Kieff; E S Mocarski; T Chittenden
Journal:  Proc Natl Acad Sci U S A       Date:  1999-10-26       Impact factor: 11.205

Review 2.  Regulation of apoptosis by viral gene products.

Authors:  J G Teodoro; P E Branton
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

3.  Dendritic cells need T cell help to prime cytotoxic T cell responses to strong antigens.

Authors:  A M Livingstone; M Kuhn
Journal:  Eur J Immunol       Date:  1999-09       Impact factor: 5.532

4.  The human cytotoxic T-lymphocyte (CTL) response to cytomegalovirus is dominated by structural protein pp65: frequency, specificity, and T-cell receptor usage of pp65-specific CTL.

Authors:  M R Wills; A J Carmichael; K Mynard; X Jin; M P Weekes; B Plachter; J G Sissons
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  Identification of the major late human cytomegalovirus matrix protein pp65 as a target antigen for CD8+ virus-specific cytotoxic T lymphocytes.

Authors:  E McLaughlin-Taylor; H Pande; S J Forman; B Tanamachi; C R Li; J A Zaia; P D Greenberg; S R Riddell
Journal:  J Med Virol       Date:  1994-05       Impact factor: 2.327

6.  Anti-human cytomegalovirus activity of cytokines produced by CD4+ T-cell clones specifically activated by IE1 peptides in vitro.

Authors:  J L Davignon; P Castanié; J A Yorke; N Gautier; D Clément; C Davrinche
Journal:  J Virol       Date:  1996-04       Impact factor: 5.103

7.  Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor.

Authors:  E A Walter; P D Greenberg; M J Gilbert; R J Finch; K S Watanabe; E D Thomas; S R Riddell
Journal:  N Engl J Med       Date:  1995-10-19       Impact factor: 91.245

8.  Human cytomegalovirus IE1 and IE2 proteins block apoptosis.

Authors:  H Zhu; Y Shen; T Shenk
Journal:  J Virol       Date:  1995-12       Impact factor: 5.103

9.  Consequences of cell death: exposure to necrotic tumor cells, but not primary tissue cells or apoptotic cells, induces the maturation of immunostimulatory dendritic cells.

Authors:  B Sauter; M L Albert; L Francisco; M Larsson; S Somersan; N Bhardwaj
Journal:  J Exp Med       Date:  2000-02-07       Impact factor: 14.307

10.  Alkali hydrolysis of recombinant proteins allows for the rapid identification of class I MHC-restricted CTL epitopes.

Authors:  M A Gavin; M J Gilbert; S R Riddell; P D Greenberg; M J Bevan
Journal:  J Immunol       Date:  1993-10-15       Impact factor: 5.422

View more
  25 in total

Review 1.  Cross-presentation: dendritic cells and macrophages bite off more than they can chew!

Authors:  Sven Brode; Paul A Macary
Journal:  Immunology       Date:  2004-07       Impact factor: 7.397

2.  Immunogenicity of cytopathic and noncytopathic viral vectors.

Authors:  Gabriela Plesa; Philip M McKenna; Matthias J Schnell; Laurence C Eisenlohr
Journal:  J Virol       Date:  2006-07       Impact factor: 5.103

3.  Presentation of Toxoplasma gondii antigens via the endogenous major histocompatibility complex class I pathway in nonprofessional and professional antigen-presenting cells.

Authors:  Florence Dzierszinski; Marion Pepper; Jason S Stumhofer; David F LaRosa; Emma H Wilson; Laurence A Turka; Sandra K Halonen; Christopher A Hunter; David S Roos
Journal:  Infect Immun       Date:  2007-09-10       Impact factor: 3.441

4.  Cross-presentation of human cytomegalovirus pp65 (UL83) to CD8+ T cells is regulated by virus-induced, soluble-mediator-dependent maturation of dendritic cells.

Authors:  Géraldine Arrode; Claire Boccaccio; Jean-Pierre Abastado; Christian Davrinche
Journal:  J Virol       Date:  2002-01       Impact factor: 5.103

5.  Antigen cross-presentation by dendritic cell subsets: one general or all sergeants?

Authors:  Stefan Nierkens; Jurjen Tel; Edith Janssen; Gosse J Adema
Journal:  Trends Immunol       Date:  2013-03-27       Impact factor: 16.687

6.  Ex vivo stimulation and expansion of both CD4(+) and CD8(+) T cells from peripheral blood mononuclear cells of human cytomegalovirus-seropositive blood donors by using a soluble recombinant chimeric protein, IE1-pp65.

Authors:  J Vaz-Santiago; J Lulé; P Rohrlich; C Jacquier; N Gibert; E Le Roy; D Betbeder; J L Davignon; C Davrinche
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

7.  Human cytomegalovirus UL76 encodes a novel virion-associated protein that is able to inhibit viral replication.

Authors:  Shang-Kwei Wang; Chang-Yih Duh; Cheng-Wen Wu
Journal:  J Virol       Date:  2004-09       Impact factor: 5.103

8.  Human CD141+ (BDCA-3)+ dendritic cells (DCs) represent a unique myeloid DC subset that cross-presents necrotic cell antigens.

Authors:  Sarah L Jongbloed; Andrew J Kassianos; Kylie J McDonald; Georgina J Clark; Xinsheng Ju; Catherine E Angel; Chun-Jen J Chen; P Rod Dunbar; Robert B Wadley; Varinder Jeet; Annelie J E Vulink; Derek N J Hart; Kristen J Radford
Journal:  J Exp Med       Date:  2010-05-17       Impact factor: 14.307

9.  Nef modulates the immunogenicity of Gag encoded in a non-infectious HIV DNA vaccine.

Authors:  Geraldine Arrode; Ramakrishna Hegde; Yuhuai Jin; Dinesh Kumar Singh; Opendra Narayan; Yahia Chebloune
Journal:  Vaccine       Date:  2008-06-17       Impact factor: 3.641

10.  Impaired lymphoid chemokine-mediated migration due to a block on the chemokine receptor switch in human cytomegalovirus-infected dendritic cells.

Authors:  Magdalena Moutaftsi; Paul Brennan; Stephen A Spector; Zsuzsanna Tabi
Journal:  J Virol       Date:  2004-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.